Asthma: new indication for SpirivaÂ® (tiotropium) RespimatÂ®* in the EU may offer millions of adults a significant advance in asthma care. Ingelheim, Germany, 8 September, 2014 â Boehringer Ingelheim today announced that the indication for SpirivaÂ® (tiotropium) RespimatÂ®* in asthma has been accepted by the regulatory authorities in the EU.